Showing 5761-5770 of 5956 results for "".
- Falls in Elders May Be Driving Up Secondary Diagnoses of Eye Traumahttps://modernod.com/news/falls-in-elders-may-be-driving-up-secondary-diagnoses-of-eye-trauma/2479788/Hospital admissions due to eye trauma have declined since 2001, but more and more patients are being admitted with a secondary diagnosis of eye trauma, largely due to an increase in falls among older people, new findings suggest, according to a Reuters
- IGF1-Targeting Teprotumumab Tackles Thyroid Eye Diseasehttps://modernod.com/news/igf1-targeting-teprotumumab-tackles-thyroid-eye-disease/2479794/Patients with moderate to severe thyroid-associated ophthalmopathy show significant improvements with treatment with teprotumumab (River Vision Development) extending as far out as 72 weeks, according to a report in Medscape. ̶
- Konan Medical USA Acquires objectiveFIELD Objective Perimeterhttps://modernod.com/news/konan-medical-usa-acquires-objectivefield-objective-perimeter/2479795/Konan Medical USA has acquired objectiveFIELD, an FDA-cleared device designed to assess the human visual field in an objective and non-contact manner. The device was acquired from the Australian National University (ANU), includes novel features licensed from Seeing Machine
- Sensimed Announces Approval of the Sensimed Triggerfish in Japanhttps://modernod.com/news/sensimed-announces-approval-of-the-sensimed-triggerfish-in-japan/2479800/Sensimed has announced the registration of the Sensimed Triggerfish sensor and monitoring system as a medical device in Japan. The Japanese partner and distributor of Sensimed, SEED Co., h
- Vision Ophthalmology Group Acquires MED Medical Products GmbHhttps://modernod.com/news/vision-ophthalmology-group-acquires-med-medical-products-gmbh/2479803/Vision Ophthalmology Group (VOG) has announced the acquisition of MED Medical Products, effective immediately. Terms of the deal were not disclosed. Karlstein, Germany-based MED is a specialist producer of customized procedure packs and disposable products used in ophthalmic surgery
- Silgan Dispensing Introduces Iridya Eye Dropper to Ensure Accurate Doses Down to the Drophttps://modernod.com/news/silgan-dispensing-introduces-iridya-eye-dropper-to-ensure-accurate-doses-down-to-the-drop/2479804/Silgan Dispensing has launched Iridya, a next-generation, multi-dose preservative-free eye dropper. The Iridya eye dropper ensures consumers an accurate dose and an easy-to-use design, while also providing safe delivery of ophthalmic medication. Its elongated tip provides greater accuracy when di
- High Dose of Sildenafil Tied to Long-term Retinal Damage in Case Reporthttps://modernod.com/news/high-dose-of-sildenafil-tied-to-long-term-retinal-damage-in-case-report/2479814/A patient who took a high dose of the erectile dysfunction drug sildenafil citrate developed long-term, and possibly irreversible, retinal damage with bilateral multicolored photopsia (perceived flashes of light) and erythropsia (red-tinted vision), according to a
- Regenxbio Completes Dosing of Fourth Cohort in Phase 1 Trial of RGX-314 Gene Therapy for Wet AMDhttps://modernod.com/news/regenxbio-completes-dosing-of-fourth-cohort-in-phase-1-trial-of-rgx-314-gene-therapy-for-wet-amd/2479815/Regenxbio announced it has completed dosing of the fourth cohort of six patients in a phase 1 clinical trial evaluating RGX-314 for the treatment of wet age-related macular degeneration (AMD). A total of 24 subjects have been dosed in the trial. The company also announced that an updated summary
- Ophthotech Completes Patient Recruitment for Its Phase 2b Clinical Trial of Zimura for Geographic Atrophy Secondary to Dry AMDhttps://modernod.com/news/ophthotech-completes-patient-recruitment-for-its-phase-2b-clinical-trial-of-zimura-for-geographic-atrophy-secondary-to-dry-amd/2479816/Ophthotech announced completion of patient recruitment for its phase 2b clinical trial of Zimura (avacincaptad pegol), the company’s complement factor C5 inhibitor, monotherapy in patients with geographic atrophy secondary to dry age-related macular degeneration (AMD). Complement factor C5
- The Refractive Surgery Council Rolls Out New “RSC Verified” Patient Education Program for Surgeonshttps://modernod.com/news/the-refractive-surgery-council-rolls-out-new-rsc-verified-patient-education-program-for-surgeons/2479820/Refractive surgeons who want to play a leading role in patient education and signal their commitment to quality now have a new resource: The RSC Verified program, according to The Refractive Surgery Council (RSC). The program, introduced by the RSC, opens the council’s vast library o